BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1747854)

  • 1. Ultrastructural morphometry in the diagnosis of mycosis fungoides and Sézary's syndrome.
    Payne CM
    Clin Dermatol; 1991; 9(2):187-203. PubMed ID: 1747854
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a role for epigenetic factors in the pathogenesis of epidermotropic cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome)?
    Bachelez H
    Hematol J; 2001; 2(4):286-9. PubMed ID: 11920262
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node histopathology in mycosis fungoides and Sézary's syndrome.
    Scheffer E; Meijer CJ; Willemze R; van Vloten WA
    Curr Probl Dermatol; 1990; 19():105-13. PubMed ID: 2404671
    [No Abstract]   [Full Text] [Related]  

  • 7. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH; Olson LC; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A; Dhungel BM; Khan MF
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():12-5. PubMed ID: 16972946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
    Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidermotropic T lymphomas].
    Sigal-Nahum M; Brousse N; Belaïch S
    Rev Prat; 1987 May; 37(25):1423-31. PubMed ID: 3495856
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome.
    Shono Y; Suga H; Kamijo H; Fujii H; Oka T; Miyagaki T; Shishido-Takahashi N; Sugaya M; Sato S
    Acta Derm Venereol; 2019 Jul; 99(9):809-812. PubMed ID: 31045236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.
    Meyerson HJ; Awadallah A; Pavlidakey P; Cooper K; Honda K; Miedler J
    Mod Pathol; 2013 Jan; 26(1):32-43. PubMed ID: 22918164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycosis fungoides and Sézary's syndrome show distinct histomorphological features.
    Imai S; Burg G; Braun-Falco O
    Dermatologica; 1986; 173(3):131-5. PubMed ID: 3770259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is bone marrow biopsy necessary in patients with mycosis fungoides and Sézary syndrome? A histological and molecular study at diagnosis and during follow-up.
    Beylot-Barry M; Parrens M; Delaunay M; Thiebault R; Vergier B; DeMascarel A; Dubus P; Beylot C; Merlio JP
    Br J Dermatol; 2005 Jun; 152(6):1378-9. PubMed ID: 15949023
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS).
    Jothishankar B; Venkataraman G; Goldberg RC; Abdulla F
    Ann Diagn Pathol; 2019 Dec; 43():151404. PubMed ID: 31629155
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycosis fungoides. Diagnosis and pathogenesis.
    Barcos M
    Am J Clin Pathol; 1993 Apr; 99(4):452-8. PubMed ID: 8475912
    [No Abstract]   [Full Text] [Related]  

  • 17. Memorials and mandates for cutaneous lymphomas.
    Heald PW
    Arch Dermatol; 2003 Jul; 139(7):926-8. PubMed ID: 12873891
    [No Abstract]   [Full Text] [Related]  

  • 18. Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping.
    Pulitzer MP; Horna P; Almeida J
    Cytometry B Clin Cytom; 2021 Mar; 100(2):132-138. PubMed ID: 32516521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
    Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
    Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
    LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
    Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.